niacinamide has been researched along with Ependymoma in 3 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Ependymoma: Glioma derived from EPENDYMOGLIAL CELLS that tend to present as malignant intracranial tumors in children and as benign intraspinal neoplasms in adults. It may arise from any level of the ventricular system or central canal of the spinal cord. Intracranial ependymomas most frequently originate in the FOURTH VENTRICLE and histologically are densely cellular tumors which may contain ependymal tubules and perivascular pseudorosettes. Spinal ependymomas are usually benign papillary or myxopapillary tumors. (From DeVita et al., Principles and Practice of Oncology, 5th ed, p2018; Escourolle et al., Manual of Basic Neuropathology, 2nd ed, pp28-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pediatric ependymomas are highly recurrent tumors resistant to conventional chemotherapy." | 1.40 | Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells. ( Adamski, J; Agnihotri, S; Barszczyk, M; Buczkowicz, P; Castelo-Branco, P; Dirks, PB; Elizabeth, C; Golbourn, B; Hawkins, C; Li, XN; Luu, B; Mack, SC; Mangerel, J; Morrison, A; Nethery-Brokx, K; Pajovic, S; Ramaswamy, V; Remke, M; Rutka, JT; Tabori, U; Taylor, MD; Van Meter, T; Yu, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barszczyk, M | 1 |
| Buczkowicz, P | 1 |
| Castelo-Branco, P | 1 |
| Mack, SC | 1 |
| Ramaswamy, V | 1 |
| Mangerel, J | 1 |
| Agnihotri, S | 1 |
| Remke, M | 1 |
| Golbourn, B | 1 |
| Pajovic, S | 1 |
| Elizabeth, C | 1 |
| Yu, M | 1 |
| Luu, B | 1 |
| Morrison, A | 1 |
| Adamski, J | 1 |
| Nethery-Brokx, K | 1 |
| Li, XN | 1 |
| Van Meter, T | 1 |
| Dirks, PB | 1 |
| Rutka, JT | 1 |
| Taylor, MD | 1 |
| Tabori, U | 1 |
| Hawkins, C | 1 |
| Sie, M | 1 |
| den Dunnen, WF | 1 |
| Lourens, HJ | 1 |
| Meeuwsen-de Boer, TG | 1 |
| Scherpen, FJ | 1 |
| Zomerman, WW | 1 |
| Kampen, KR | 1 |
| Hoving, EW | 1 |
| de Bont, ES | 1 |
| Coper, H | 1 |
1 trial available for niacinamide and Ependymoma
| Article | Year |
|---|---|
[Studies of the NAD(P) glycohydrolase activity in human brain tumors].
Topics: Adenoma, Chromophobe; Astrocytoma; Brain Neoplasms; Clinical Trials as Topic; Enzyme Induction; Epen | 1967 |
2 other studies available for niacinamide and Ependymoma
| Article | Year |
|---|---|
Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells.
Topics: Animals; Brain Neoplasms; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Child, Preschool; Co | 2014 |
Growth-factor-driven rescue to receptor tyrosine kinase (RTK) inhibitors through Akt and Erk phosphorylation in pediatric low grade astrocytoma and ependymoma.
Topics: Apoptosis; Astrocytoma; Brain Neoplasms; Cell Line, Tumor; Cell Movement; Crizotinib; Dasatinib; Epe | 2015 |